Insider Shareholders with Direct Ownership of Homology Medicines, Inc. (FIXX)
This section provides a comprehensive overview of the insiders with direct ownership of Homology Medicines, Inc. (FIXX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Homology Medicines, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Novartis Institutes For Bio Medical Research, Inc.
> 10% Shareholder |
1,979,226 | 0 | 1,979,226 $0 | 1 |
Apr 02, 2018
Added 50.0%
|
| 20,130 | 31,729 | 150,874 $0 | 9 |
Sep 06, 2023
Reduced 0.95%
|
|
|
Shelia M. Violette
Chief Scientific Officer |
23,874 | 0 | 23,874 $0 | 3 |
Oct 15, 2024
Added 20.08%
|
|
W Bradford Smith
Officer |
33,630 | 19,411 | 14,219 $0 | 6 |
Jan 09, 2023
Reduced 20.78%
|
|
Michael Lee Blum
Chief Commercial Officer |
7,590 | 2,454 | 13,538 $0 | 2 |
Jan 09, 2023
Reduced 15.35%
|
| 81,375 | 29,272 | 7,983 $0 | 8 |
Mar 25, 2024
Reduced 3.21%
|
|
|
Julie Jordan
Chief Medical Officer |
6,929 | 1,952 | 7,496 $0 | 4 |
Aug 03, 2023
Reduced 14.86%
|
|
Gabriel Cohn
Chief Medical Officer |
4,290 | 1,661 | 2,629 $0 | 2 |
Jan 05, 2022
Reduced 38.72%
|
| 51,710 | 21,603 | 2,596 $0 | 7 |
Mar 25, 2024
Reduced 9.36%
|
|
|
Timothy P Kelly
Chief Operating Officer |
22,862 | 10,460 | 2,224 $0 | 12 |
Jan 05, 2022
Reduced 38.73%
|
| 10,688 | 1,783 | 927 $0 | 4 |
Mar 25, 2024
Reduced 7.49%
|